Gut microbiota, blood metabolites, & pan-cancer: a bidirectional Mendelian randomization & mediation analysis

被引：0

作者：

Biqing Luan ^{[1
]}

Yang Yang ^{[2
]}

Qizhi Yang ^{[1
]}

Zhiqiang Li ^{[1
]}

Zhihui Xu ^{[1
]}

Yaqin Chen ^{[1
]}

Meiting Wang ^{[1
]}

Wenlin Chen ^{[2
]}

Fei Ge ^{[1
]}

机构：

[1] First Affiliated Hospital of Kunming Medical University,Department of Breast Surgery

[2] The Third Affiliated Hospital of Kunming Medical University,Yunnan Key Laboratory of Breast Cancer Precision Medicine, Department of breast surgery

[3] Peking University Cancer Hospital Yunnan,undefined

[4] Yunnan Cancer Hospital,undefined

来源：

AMB Express | / 15卷 / 1期

关键词：

Gut microbiota; Pan-cancer; Blood metabolites; Mendelian randomization; Mediation analysis; Metabolic pathway enrichment analysis;

D O I：

10.1186/s13568-025-01866-w

中图分类号：

学科分类号：

摘要：

We propose using Mendelian randomization analysis on GWAS data and MetaboAnalyst to model gut microbiota, metabolic pathways, blood metabolites, and cancer risk. We examined 473 gut microbiota, 205 pathways, 1400 metabolites, and 8 cancers. Results were validated through bidirectional two-sample Mendelian Randomization (MR), heterogeneity tests, and pathway enrichment, leading to a mediation pathway model. We identified 129 gut microbiota, 57 pathways, and 463 metabolites linked to cancer, and 34 significant plasma pathways. 15 microbiota, 8 pathways, and 58 metabolites implicated in multiple cancers. Eight plasma metabolic pathways are involved in the development of multiple types of cancer. Through Multivariate Mendelian Randomization (MVMR) and mediation analysis, we found 9 mediation pathways, offering novel targets and research directions for cancer pathogenesis and treatment.

引用

共 50 条

[1] Gut microbiota and autoimmune thyroid disease: a bidirectional Mendelian randomization study and mediation analysis
Fang, Yiqiao
Zhang, Xinyue
Huang, Rui
Liu, Jiaye
Li, Zhihui
FRONTIERS IN MICROBIOLOGY, 2024, 15
[2] Mediation analysis of gut microbiota and plasma metabolites in asthma pathogenesis using Mendelian randomization
Zheng, Xuwen
Yin, Jinnan
Zhao, Liang
Qian, Yongjun
Xu, Jin
JOURNAL OF ASTHMA, 2025,
[3] Gut Microbiota, Human Blood Metabolites, and Esophageal Cancer: A Mendelian Randomization Study
Li, Xiuzhi
Xu, Bingchen
Yang, Han
Zhu, Zhihua
GENES, 2024, 15 (06)
[4] Gut microbiota and blood metabolites: unveiling their roles in hippocampal volume changes through Mendelian randomization and mediation analysis
Zijin Huang
Xueke Du
Fangzhou Li
Zhixuan Lan
Liang Guo
Linghui Pan
Metabolic Brain Disease, 40 (4)
[5] Blood metabolites reflect the effect of gut microbiota on differentiated thyroid cancer: a Mendelian randomization analysis
Zhang, Hanfei
Li, Yuhao
Li, Lin
BMC CANCER, 2025, 25 (01)
[6] The role of gut microbiota and blood metabolites in postpartum depression: a Mendelian randomization analysis
Cui, Ji
Zhai, Qilong
Yang, Zhu
Liu, Yi
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2024, 14
[7] The gut-facial aging axis: A two-sample Mendelian randomization and mediation analysis of gut microbiota, gut microbiota metabolic pathways, and blood metabolites
Yang, Sha
Zhao, Ying
Liu, Jian
Song, Jianning
Long, Qingyan
Cheng, Si
SKIN RESEARCH AND TECHNOLOGY, 2024, 30 (08)
[8] Gut microbiota and sepsis: bidirectional Mendelian study and mediation analysis
Zhang, Zhi
Cheng, Lin
Ning, Dong
FRONTIERS IN IMMUNOLOGY, 2023, 14
[9] Potential mechanisms of gut microbiota influence on different types of vertigo: a bidirectional Mendelian randomization and mediation analysis
Rong, Qiongwen
Chen, Hao
Chen, Yibin
Xu, Minghui
Chen, Ruixue
Li, Changxuan
BMC NEUROLOGY, 2024, 24 (01)
[10] Causal associations between constipation and pan-cancer: a bidirectional Mendelian randomization study
Dang, Yongze
He, Xinyu
Liu, Xiaoxiao
Wang, Yuchen
Geng, Shangyi
Cheng, Yutong
Ma, Hongbing
Zhao, Xixi
FRONTIERS IN ONCOLOGY, 2024, 14

← 1 2 3 4 5 →